| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |